Publications

Export 704 results:
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Timsit Y, Shatzky-Schwartz M., Shakked Z..  1999.  Left-handed DNA crossovers. Implications for DNA-DNA recognition and structural alterations. J. Biomol. Struct. Dyn.. 16:775–785.
Timsit Y, Moras D..  1994.  DNA self-fitting: the double helix directs the geometry of its supramolecular assembly. Embo J.. 13:2737–2746.
Timsit Y, Moras D..  1996.  Cruciform structures and functions. Q. Rev. Biophys.. 29:279–307.
Timsit Y, Moras D..  1992.  Crystallization of DNA. Meth. Enzymol.. 211:409–429.
Timsit Y, Duplantier B., Jannink G., Sikorav J.L..  1998.  Symmetry and chirality in topoisomerase II-DNA crossover recognition. J. Mol. Biol.. 284:1289–1299.
Timsit Y, Allemand F., Chiaruttini C., Springer M..  2006.  Coexistence of two protein folding states in the crystal structure of ribosomal protein L20. Embo Rep.. 7:1013–1018.
Timsit Y, Moras D..  1995.  Self-fitting and self-modifying properties of the B-DNA molecule. J. Mol. Biol.. 251:629–647.
Timsit Y, Allemand F, C C, Springer M.  2008.  Order-disorder transitions in ribosome assembly. Ribosomal proteins,.
Timsit Y, Vilbois E., Moras D..  1991.  Base-pairing shift in the major groove of (CA)n tracts by B-DNA crystal structures. Nature. 354:167–170.
Timsit Y.  2001.  Convergent evolution of MutS and topoisomerase II for clamping DNA crossovers and stacked Holliday junctions. J. Biomol. Struct. Dyn.. 19:215–218.
Thevenet P, Shen Y, Maupetit J, Guyon F, Derreumaux P, Tuffery P.  2012.  PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res.. 40:W288-W293.
Thevenet P., Shen Y., Maupetit J., Guyon F., Padilla A., Derreumaux P., Tuffery P.  2012.  Delivering the native structures of peptides from computer simulations and predicted NMR proton chemical shifts. J. Pept. Sci.. 18:S38.
Tek A., Baaden M., Férey N., Bourdot P..  2013.  MANHaptic: A Haptic Adaptive Method for Precise Manipulation, Assembly \and Navigation. International Journal on Human Machine Interaction. 1:60–67.
Tek A., Laurent B., Piuzzi M., Lu Z., Baaden M., Delalande O., Chavent M, Férey N., Martin C., Piccinali L. et al..  2012.  Advances in Human-Protein Interaction - Interactive And Immersive Molecular Simulations.
Tek A, Laurent B, Férey N, Baaden M.  2010.  Interacting with Molecular Simulations using a Multimodal VR Framework. EuroVR-EVE. :1–4.
Tarus B, Nguyen PH, Berthoumieu O, Faller P, Doig AJ, Derreumaux P.  2015.  Molecular structure of the NQTrp inhibitor with the Alzheimer A beta 1-28 monomer. Eur. J. Med. Chem.. 91:43–50.
Tarus B, Tran T-T, Nasica-Labouze J, Sterpone F, Nguyen PH, Derreumaux P.  2015.  Structures of the Alzheimer’s Wild-Type A beta 1-40 Dimer from Atomistic Simulations. J. Phys. Chem. B. 119:10478–10487.
Taly A, Corringer P.J, Grutter T., L. de Carvalho P, Karplus M., Changeux J-P.  2006.  Implications of the quaternary twist allosteric model for the physiology and pathology of nicotinic acetylcholine receptors. Proc. Natl. Acad. Sci. U.s.a.. 103:16965–16970.
Taly A, Delarue M., Grutter T., Nilges M., Le Novere N., Corringer P.J, Changeux J-P.  2005.  Normal mode analysis suggests a quaternary twist model for the nicotinic receptor gating mechanism. Biophys. J.. 88:3954–3965.
Taly A, Corringer P-J, Grutter T, De Carvalho LPrado, Karplus M, Changeux J-P.  2006.  Implications of the quaternary twist allosteric model for the physiology and pathology of nicotinic acetylcholine receptors. Proceedings of the National Academy of Sciences. 103:16965–16970.
Taly A.  2013.  Novel approaches to drug design for the treatment of schizophrenia. Expert Opin. Drug Discovery. 8:1285–1296.
Taly A.  2007.  Opened by a twist: a gating mechanism for the nicotinic acetylcholine receptor. Eur. Biophys. J.. 36:911–918.
Taly A, Sebban P, Smith JC, G Ullmann M.  2003.  The position of Q B in the photosynthetic reaction center depends on pH: A theoretical analysis of the proton uptake upon Q B reduction. Biophys. J.. 84:2090–2098.
Taly A, Corringer P.J, Guedin D., Lestage P., Changeux J-P.  2009.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat. Rev. Drug Discov.. 8:733–750.
Taly A, Charon S.  2012.  $\alpha$7 nicotinic acetylcholine receptors: a therapeutic target in the structure era. Curr. Drug Targets. 13:695–706.

Pages